查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1496723

神經血管介入器材的全球市場：按產品、工藝、適應症和最終用途 - 預測（2024-2030）

Neurovascular Intervention Devices Market by Product (Balloon Systems, Carotid Stents, Catheters), Process (Carotid Endarterectomy, Cerebral Angiography, Coiling), Indication, End-use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年全球神經血管介入器材市場規模為40.1億美元，2024年達42.5億美元，2030年達62.1億美元，複合年成長率為6.46%。

神經血管介入設備是先進的醫療設備，旨在治療影響大腦和神經系統血管的神經血管疾病。這些醫療設備可以對動脈瘤、動靜脈畸形 (AVM) 和缺血性中風等疾病進行微創手術。這些包括支架、栓塞彈簧圈、分流器、微導管和血栓移除裝置。由於神經血管疾病的複雜性和神經系統的關鍵功能，這些儀器的使用需要高精度和熟練的介入性神經科。中風、動脈瘤和狹窄等神經血管疾病的盛行率不斷增加，增加了對神經血管介入設備的需求。微創手術因其住院時間短、恢復時間短、併發症風險低等優點，比傳統手術越來越受到青睞。神經血管介入的成功很大程度上取決於熟練專業人員和先進醫療基礎設施的可用性，而某些地區可能缺乏這些基礎設施。神經血管介入需要高精度和技術。然而，設備設計和性能的技術限制，例如複雜血管結構中的導航困難，可能會導致手術併發症。領先的公司正在進行持續的研究和開發，旨在創造更先進、可靠和安全的神經血管介入設備。其中包括改進的導航功能、更有效的血栓清除以及加速血管癒合的設備。將人工智慧和機器人技術整合到神經血管介入中可以提高準確性、減少手術時間並改善患者的治療效果。

主要市場統計
基準年[2023] 40.1億美元
預計年份 [2024] 42.5億美元
預測年份 [2030] 62.1億美元
複合年成長率（%） 6.46%

區域洞察

以美國和加拿大為中心的美洲地區由於先進的醫療基礎設施、較高的患者意識以及大量的研發投資，是神經血管介入器材高度發達的地區。該地區的客戶正在尋求能夠快速康復的創新微創解決方案，並且需要具有經過驗證的功效和安全性的產品。美國最近的專利專注於提高設備精度和減少手術併發症。儘管設備的核准程序很嚴格，但加拿大的全民健保系統支持患者獲得這些治療。由於醫療保健支出的增加，亞太地區神經血管介入設備市場正在迅速擴大。老化人口中神經系統疾病的日益流行也推動了神經血管介入設備的採用。本土製造商正大力投資研發，以與國際品牌競爭。日本因其高額醫療支出和先進技術而成為亞太地區的主要貢獻者，患者對有臨床證據支持的創新有著強烈的渴望。印度市場的特點是，由於醫療意識的提高和醫療基礎設施的改善，對神經血管治療的需求不斷成長。歐盟的患者通常需要高品質且耐用的神經血管設備。歐盟最近的舉措著重於協調監管要求，以簡化設備核准流程，使製造商和患者受益。有關醫療設備性能、功效、安全性和製造的嚴格法規為神經血管介入器械的進步和採用創建了標準化框架。

FPNV定位矩陣

FPNV 定位矩陣對於評估供應商在神經血管介入設備市場的定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對神經血管介入器材市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭性質的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在神經血管介入器械市場中的地位進行全面評估可以幫助公司做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球神經血管疾病的發生率增加
      • 人們對微創手術的興趣日益濃厚
    • 抑制因素
      • 神經血管介入器材缺乏報銷場景和產品召回
    • 機會
      • 神經血管介入器材的技術進展
      • 增加神經血管研發和治療中心的投資
    • 任務
      • 神經血管介入裝置操作的技術限制
  • 市場區隔分析
    • 產品：導管在各類血管內神經外科手術的基本作用
    • 流程：擴大神經血管介入器材在腦血管造影術的使用
    • 症狀：用於治療缺血性中風的神經血管介入裝置的使用迅速增加
    • 最終用途：醫院綜合設備和專業人員擴大神經血管介入設備的部署
  • 市場趨勢分析
    • 美洲神經血管醫療基礎設施的進步和成熟的介入設備提供者的存在
    • 技術創新和強大的醫療基礎設施推動神經血管介入設備在亞太地區的使用
    • 歐洲、中東和非洲對神經血管介入器材的監管核准增加
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析

第6章神經血管介入設備市場：依產品

  • 氣球系統
  • 頸動脈支架
  • 導管
  • 栓塞彈簧圈
  • 栓塞防護裝置
  • 分流器
  • 導管導引線
  • 顱內支架
  • 囊內裝置
  • 神經血栓切除裝置

第7章神經血管介入設備市場：依流程

  • 頸動脈切除術
  • 腦血管血管造影術
  • 卷繞
  • 流晶粒版本
  • 顯微外科夾閉
  • 神經血栓切除術
  • 支架

第8章神經血管介入設備市場：依情況分類

  • 動靜脈畸形
  • 腦動脈瘤
  • 缺血性中風
  • 狹窄治療

第9章神經血管介入設備市場：依最終用途分類

  • 門診手術中心
  • 醫院
  • 專科診所

第10章美洲神經血管介入器材市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太神經血管介入器材市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲神經血管介入器材市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 市場佔有率分析（2023）
  • FPNV定位矩陣（2023）
  • 競爭情境分析
    • Baylis Medical Technologies 推出 PowerWire Pro 射頻導管導引線以增強靜脈支架再通
    • S3V Vascular Technologies 獲得了 300 億盧比的 B 輪資金籌措，用於神經血管介入創新，吸引了精英投資者的興趣。
    • Nanoflex Robotics 推出用於神經血管介入的創新遠端控制系統
    • Zylox-Tonbridge 與 Avinger 建立策略夥伴關係，推動大中華區神經血管介入創新
    • 飛利浦推出先進的 Azurion 神經雙翼干預系統
    • 推出 CEREGLIDE 71 - CERENOVUS 的 TruCourse 技術在中風介入上取得突破
    • Obasnaich 和 Abbott CSI 將美國獨家分銷合作夥伴關係延長至 2027 年
    • Sensome 和 Asahi Intecc 合作開發由人工智慧驅動的先進 Clotild 智慧導絲
    • Stryker 收購 Cerus Endoangio 擴大神經血管介入產品範圍
    • Infinity Neuro 的 Inspira 抽吸導管獲得 CE 標誌

第14章競爭組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-ED54C46E8FA1

[183 Pages Report] The Neurovascular Intervention Devices Market size was estimated at USD 4.01 billion in 2023 and expected to reach USD 4.25 billion in 2024, at a CAGR 6.46% to reach USD 6.21 billion by 2030.

Neurovascular intervention devices are advanced medical apparatuses designed for the treatment of neurovascular disorders that affect the blood vessels in the brain and the nervous system. These devices enable minimally invasive procedures for conditions such as aneurysms, arteriovenous malformations (AVMs), and ischemic strokes. They include stents, embolic coils, flow diverters, microcatheters, and clot retrieval devices. The application of these devices requires high precision and skilled interventional neurologists due to the complex nature of neurovascular diseases and the critical function of the nervous system. The rising prevalence of neurovascular conditions, including strokes, aneurysms, and stenosis, has driven the need for neurovascular intervention devices. There is a growing inclination toward minimally invasive surgeries over traditional surgeries due to benefits such as shorter hospital stays, reduced recovery time, and lower risk of complications. The successful implementation of neurovascular interventions is highly dependent on the availability of skilled professionals and advanced healthcare infrastructure, which can be lacking in some regions. Neurovascular interventions require high precision and skill. However, technical limitations in device design and performance, such as navigation difficulties in complex vascular structures, can lead to procedural complications. Key players are exploring ongoing research and development efforts aimed at creating more advanced, reliable, and safer neurovascular intervention devices. These include devices with improved navigability, effectiveness in clot removal, and devices that promote faster vessel healing. The integration of AI and robotics in neurovascular interventions can enhance precision, reduce procedure times, and potentially improve patient outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 4.01 billion
Estimated Year [2024] USD 4.25 billion
Forecast Year [2030] USD 6.21 billion
CAGR (%) 6.46%

Regional Insights

The Americas region, particularly the U.S. and Canada, presents a highly developed landscape for neurovascular intervention devices due to its advanced healthcare infrastructure, high patient awareness, and significant investment in R&D. Customers here require innovative, minimally invasive solutions that offer quick recovery and have a strong preference for products with proven efficacy and safety. Recent patents in the U.S. have focused on enhancing device accuracy and reducing procedural complications. Canada's universal healthcare system supports patient access to these interventions, although the device approval process can be stringent. APAC's neurovascular intervention devices market is rapidly expanding, owing to its growing healthcare expenditure. The increased prevalence of neurological disorders among its aging population also necessitated the adoption of neurovascular intervention devices. Local manufacturers are investing heavily in R&D, striving to compete with international brands. Japan is a major contributor in the Asia-Pacific region due to its high healthcare spending and technological sophistication, and patients strongly prefer innovation backed by clinical evidence. The Indian market is characterized by a growing need for neurovascular treatments due to increasing healthcare awareness and improving healthcare infrastructure. EU patients generally seek high-quality, durable neurovascular devices. Recent EU initiatives have focused on harmonizing regulatory requirements to streamline device approval processes, benefitting manufacturers and patients. Stringent regulations pertaining to the performance, efficacy, safety, and manufacture of medical devices have created a standardized framework for the progress and adoption of neurovascular intervention devices.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Neurovascular Intervention Devices Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing incidence of neurovascular diseases worldwide
      • Growing preference for minimally invasive procedures
    • Market Restraints
      • Lack of reimbursement scenario and product recall for neurovascular intervention devices
    • Market Opportunities
      • Technological advancements in neurovascular intervention devices
      • Rising investments in neurovascular R&D and treatment center
    • Market Challenges
      • Technical limitations of operating neurovascular intervention devices
  • Market Segmentation Analysis
    • Product: Fundamental role of catheters in various types of endovascular neurosurgical procedures
    • Process: Proliferating utilization of neurovascular intervention devices in cerebral angiography
    • Indication: Burgeoning utilization of neurovascular intervention devices for ischemic strokes
    • End-use: Comprehensive facilities and specialized personnel in hospitals expanding the adoption of neurovascular intervention devices
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Neurovascular Intervention Devices Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Neurovascular Intervention Devices Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Baylis Medical Technologies Introduces PowerWire Pro RF Guidewire for Enhanced Venous Stent Recanalization

Baylis Medical Technologies Inc., announced the 510(k) clearance and subsequent launch of its PowerWire Pro Radiofrequency (RF) Guidewire in the United States. Specifically engineered for venous stent recanalization in cases of complete occlusion, this innovative device utilizes radiofrequency technology to navigate through totally occluded peripheral vessel stents. [Published On: 2024-03-20]

S3V Vascular Technologies Secures Key Series B Funding of INR 300 Crore for Neurovascular Intervention Innovation, Attracting Elite Investor Interest

S3V Vascular Technologies secured a robust financial investment of INR 300 crore in Series B funding. The investment highlights a growing confidence in S3V Vascular Technologies' innovative approaches and product offerings in the neurovascular domain. This capital contributes to expanding the company's product line, enhancing its research and development capabilities, and broadening its market reach, particularly in the neurovascular intervention space. [Published On: 2024-03-15]

Nanoflex Robotics Deployed Revolutionary Remote-Operable System for Neurovascular Interventions

Nanoflex Robotics, a Switzerland-based innovator, deployed its remote-capable robotics system at the Jacobs Institute in Buffalo, USA, marking a significant advancement in neurovascular intervention technology. The system integrates a compact magnetic field generator with a navigation control unit, enabling physicians to precisely control, maneuver, and guide ultra-flexible devices through the intricate pathways of the body's vasculature. This breakthrough technology facilitates a wide array of complex vascular interventions by allowing direct manipulation of the guidewire's tip, dramatically enhancing the precision and safety of these procedures. [Published On: 2024-03-11]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Neurovascular Intervention Devices Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Neurovascular Intervention Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Asahi Intecc Co., Ltd., Balt Group, Boston Scientific Corporation, Carl Zeiss AG, Edwards Lifesciences Corporation, Evasc Medical Systems Corp., GE Healthcare, Imperative Care Inc., Integer Holdings Corporation, Japan Lifeline Co., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co., Ltd., LivaNova PLC, Medikit Co., Ltd., Medtronic PLC, Merit Medical Systems, Inc., Microport Scientific Corporation, Nanoflex Robotics AG, NeuroSafe Medical Co., Ltd., Penumbra, Inc., Phenox GmbH by Wallaby Medical, LLC, Rapid Medical Ltd., Route 92 Medical, Inc., Siemens Healthineers AG, Stryker Corporation, Terumo Corporation, and Zylox-Tonbridge Medical Technology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Neurovascular Intervention Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Balloon Systems
    • Carotid Stents
    • Catheters
    • Embolic Coils
    • Embolic Protection Devices
    • Flow Diverters
    • Guidewires
    • Intracranial Stents
    • Intrasaccular Devices
    • Neurothrombectomy Devices
      • Aspiration Devices
      • Stent Retrievers
      • Ultrasound-assisted Devices
  • Process
    • Carotid Endarterectomy
    • Cerebral Angiography
    • Coiling
    • Flow Diversion
    • Microsurgical Clipping
    • Neurothrombectomy
    • Stenting
  • Indication
    • Arteriovenous Malformations
    • Cerebral Aneurysms
    • Ischemic Strokes
    • Stenosis Treatment
  • End-use
    • Ambulatory Surgical Centers
    • Hospitals
    • Speciality Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of neurovascular diseases worldwide
      • 5.1.1.2. Growing preference for minimally invasive procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of reimbursement scenario and product recall for neurovascular intervention devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in neurovascular intervention devices
      • 5.1.3.2. Rising investments in neurovascular R&D and treatment center
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations of operating neurovascular intervention devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Fundamental role of catheters in various types of endovascular neurosurgical procedures
    • 5.2.2. Process: Proliferating utilization of neurovascular intervention devices in cerebral angiography
    • 5.2.3. Indication: Burgeoning utilization of neurovascular intervention devices for ischemic strokes
    • 5.2.4. End-use: Comprehensive facilities and specialized personnel in hospitals expanding the adoption of neurovascular intervention devices
  • 5.3. Market Trend Analysis
    • 5.3.1. Advancing neurovascular healthcare infrastructure in the Americas and the presence of established intervention device providers
    • 5.3.2. Technological innovations and robust healthcare infrastructure driving use of neurovascular intervention devices in the APAC region
    • 5.3.3. Growing approvals for neurovascular intervention devices from regulatory authorities in the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Neurovascular Intervention Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Balloon Systems
  • 6.3. Carotid Stents
  • 6.4. Catheters
  • 6.5. Embolic Coils
  • 6.6. Embolic Protection Devices
  • 6.7. Flow Diverters
  • 6.8. Guidewires
  • 6.9. Intracranial Stents
  • 6.10. Intrasaccular Devices
  • 6.11. Neurothrombectomy Devices

7. Neurovascular Intervention Devices Market, by Process

  • 7.1. Introduction
  • 7.2. Carotid Endarterectomy
  • 7.3. Cerebral Angiography
  • 7.4. Coiling
  • 7.5. Flow Diversion
  • 7.6. Microsurgical Clipping
  • 7.7. Neurothrombectomy
  • 7.8. Stenting

8. Neurovascular Intervention Devices Market, by Indication

  • 8.1. Introduction
  • 8.2. Arteriovenous Malformations
  • 8.3. Cerebral Aneurysms
  • 8.4. Ischemic Strokes
  • 8.5. Stenosis Treatment

9. Neurovascular Intervention Devices Market, by End-use

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Hospitals
  • 9.4. Speciality Clinics

10. Americas Neurovascular Intervention Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Neurovascular Intervention Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Neurovascular Intervention Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Baylis Medical Technologies Introduces PowerWire Pro RF Guidewire for Enhanced Venous Stent Recanalization
    • 13.3.2. S3V Vascular Technologies Secures Key Series B Funding of INR 300 Crore for Neurovascular Intervention Innovation, Attracting Elite Investor Interest
    • 13.3.3. Nanoflex Robotics Deployed Revolutionary Remote-Operable System for Neurovascular Interventions
    • 13.3.4. Zylox-Tonbridge Forms Strategic Alliance with Avinger to Innovate Neurovascular Interventions in Greater China
    • 13.3.5. Philips Unveils Advanced Azurion Neuro Biplane Interventional System
    • 13.3.6. Introducing CEREGLIDE 71 a CERENOVUS's Breakthrough in Stroke Intervention with TruCourse Technology
    • 13.3.7. OrbusNeich and Abbott's CSI Extend Exclusive Distribution Partnership in the U.S. through 2027
    • 13.3.8. Sensome and Asahi Intecc Collaborate on Advanced AI-Powered Clotild Smart Guidewire
    • 13.3.9. Stryker's Acquired Cerus Endovascular to Expand its Offering in the Neurovascular Intervention Sector
    • 13.3.10. Infinity Neuro Secures CE Mark for Inspira Aspiration Catheters

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. NEUROVASCULAR INTERVENTION DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. NEUROVASCULAR INTERVENTION DEVICES MARKET DYNAMICS
  • FIGURE 7. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. NEUROVASCULAR INTERVENTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEUROVASCULAR INTERVENTION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BALLOON SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BALLOON SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID STENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID STENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRACRANIAL STENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRACRANIAL STENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRASACCULAR DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRASACCULAR DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ASPIRATION DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ASPIRATION DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ULTRASOUND-ASSISTED DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ULTRASOUND-ASSISTED DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID ENDARTERECTOMY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID ENDARTERECTOMY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANGIOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANGIOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COILING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COILING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERSION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERSION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROSURGICAL CLIPPING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROSURGICAL CLIPPING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANEURYSMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANEURYSMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENOSIS TREATMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENOSIS TREATMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 79. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 80. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 87. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 88. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 89. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 90. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 91. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 92. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 99. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 100. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 101. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 102. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 109. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 110. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 111. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 112. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 121. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 122. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 156. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 157. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 158. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 167. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 168. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 169. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 170. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 171. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 172. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 173. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 174. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 177. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 178. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 179. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 180. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 181. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 182. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 183. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 184. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 185. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 186. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 187. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 188. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 189. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 190. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 191. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 192. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 193. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 194. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 195. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 196. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 197. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 198. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 199. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 200. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 201. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 202. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 203. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 204. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 205. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 206. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 207. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 208. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 209. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 210. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 211. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 212. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 214. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 216. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 217. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 218. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 219. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 220. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 221. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 222. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 223. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 224. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 225. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 226. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 227. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 228. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 229. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 230. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 231. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 232. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 233. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 234. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 235. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 236. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 237. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 238. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 239. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 240. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 241. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 242. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 243. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 244. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 245. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 246. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 247. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 248. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 249. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 250. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 251. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 252. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 253. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 254. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 255. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 256. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 257. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 258. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 259. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 260. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 261. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 262. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 263. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 264. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 265. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 266. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 279. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 280. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 281. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 282. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 283. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 284. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 285. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 286. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 287. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 288. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 289. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 290. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 291. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 292. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 293. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 294. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 295. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 296. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATIO